Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase Muriel Silva Moura, Thais Celi Lopes Benevides, Marcia Torresan Delamain, Gislaine Oliveira Duarte, Priscila Oliveira Percout, Maria Almeida Dias, Roberto Zulli, Carmino Antonio de Souza, Irene Lorand-Metze, Katia Borgia Barbosa Pagnano

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga, Katia Borgia Barbosa Pagnano, Marina Dal'Bó Pelegrini Campioni, Ana Beatriz Pascoal Lopes, Gislaine Oliveira Duarte, Konradin Metze, Irene Lorand-Metze

Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon Alan Rodrigues Andrade, Daniel da Silva Leitão, Igor Penha Paz, Talitta Ribeiro Evangelista, Vanessa Joia de Mello, Moisés Hamoy